Market research
FLXN Horizon Flexible Income ETF
BATS USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 459M
- P/E ratio
- Not available
- Analyst target
- 27
- Dividend yield
- 0.0%
- Beta
- 0.0
Profile
Company facts
- Exchange
- BATS
- Currency
- USD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- US33938J1060
- Market cap
- 459M
- P/E ratio
- Not available
- Analyst target
- 27
- Dividend yield
- 0.0%
- Beta
- 0.0
About
About Horizon Flexible Income ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing primarily in non-investment grade Fixed Income Instruments. The fund"s Fixed Income Instruments may include debt or debt-related securities, income producing securities, and other instruments or evidences of indebtedness, including bonds, bills, notes, loans, money market instruments, mortgage and asset backed securities, and preferred stocks, and derivative instruments related thereto; and other investment companies that invest primarily in the foregoing instruments.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the FLXN discussion.
5 years, 4 months ago
Flexion Therapeutics, Inc is currently in a long term downtrend where the price is trading 26.1% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.7.
Flexion Therapeutics, Inc's total revenue rose by 11.2% to $26M since the same quarter in the previous year.
Its net income has increased by 41.4% to $-20M since the same quarter in the previous year.
Finally, its free cash flow grew by 73.7% to $-11M since the same quarter in the previous year.
Based on the above factors, Flexion Therapeutics, Inc gets an overall score of 4/5.